Table 3. Predicted risk of drugs applied to base-line model of cardiac cell.
| Risk label | Drug name | Predicted risk |
|---|---|---|
| High | Azimilide | Low |
| Disopyramide | Low | |
| Bepridil | High | |
| Dofetilide | High | |
| Ibutilide | High | |
| Vandetanib | High | |
| Quinidine | High | |
| Sotalol | Low | |
| Intermediate | Astemizole | Low |
| Clarithromycin | Low | |
| Chlorpromazine | Low | |
| Cisapride | Intermediate | |
| Clozapine | Low | |
| Domperidone | Low | |
| Ondansetron | Intermediate | |
| Terfenadine | Intermediate | |
| Droperidol | Intermediate | |
| Pimozide | Low | |
| Risperidone | Low | |
| Low | Loratadine | Low |
| Metoprolol | Low | |
| Diltiazem | Low | |
| Mexiletine | Low | |
| Nifedipine | Low | |
| Nitrendipine | Low | |
| Ranolazine | Intermediate | |
| Verapamil | Intermediate | |
| Tamoxifen | Low |